FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LIFIRAFENIB
异名/同义词5-(((1R,1AS,6BR)-1-(6-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOL-2-YL)-1A,6B-DIHYDRO-1H-CYCLOPROPA(B)BENZOFURAN-5-YL)OXY)-3,4-DIHYDRO-1H-1,8-NAPHTHYRIDIN-2-ONE
BEIGENE-283
BGB-283
LIFIRAFENIB
LIFIRAFENIB [INN]
LIFIRAFENIB [USAN]
LIFIRAFENIB [WHO-DD]
1,8-NAPHTHYRIDIN-2(1H)-ONE, 5-(((1R,1AS,6BR)-1A,6B-DIHYDRO-1-(6-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOL-2-YL)-1H-CYCLOPROPA(B)BENZOFURAN-5-YL)OXY)-3,4-DIHYDRO-
CAS登记号1446090-79-4
物质唯一标识(Unique Ingredient Identifier)8762XZS5ZF
分子式C25H17F3N4O3
国际化合物标识(International Chemical Identifier,InChI)NGFFVZQXSRKHBM-FKBYEOEOSA-N
SMILESFC(c1cc2[nH]c([C@@H]3[C@]4(Oc5ccc(Oc6ccnc7NC(=O)CCc76)cc5[C@]43[H])[H])nc2cc1)(F)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System